22nd Century Group, Inc. - Form 8-K Summary
Business Context and Reporting Period
Company: 22nd Century Group, Inc. (Nasdaq: XXII)
Reporting Date: December 17, 2025
Event: Entry into a Material Definitive Agreement (Omnibus Amendment and Waiver) with holders of Series A Convertible Preferred Stock.
Key Financial Metrics
This filing is a Current Report (Form 8-K) regarding corporate governance and capital structure amendments. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for these metrics.
Material Changes and Agreements
The Company entered into an Omnibus Amendment and Waiver with Preferred Stock holders to modify the terms of the Securities Purchase Agreement dated August 22, 2025. Key changes include:
- Stockholder Approval Deadline: Extended to February 23, 2026.
- Reverse Stock Split: The Company will seek stockholder approval to effect a reverse stock split to comply with Nasdaq Listing Rules.
- Future Offering: Seeking approval for a potential offering of securities (preferred stock and warrants) up to $20 million on terms similar to the current Preferred Stock.
- ATM Facility Restrictions: Prior to the Stockholder Approval Deadline, shares sold under the ATM Facility must be priced at or above $2.00 per share. Restrictions are lifted upon approval; if approval is not obtained by the deadline, ATM sales are suspended until approval is secured.
- Conversion Price Adjustments: Subject to approval, the Board may reduce the current Conversion Price. Additionally, an alternative conversion feature may be added allowing conversion at 85% of the lowest VWAP in the preceding 20 trading days.
- Warrant Protections: Subject to approval, anti-dilution adjustments will be made to Warrant exercise prices to protect against future dilutive issuances.
Outlook, Risks, and Contingencies
Contingencies: Several key provisions, including the reduction of the Conversion Price, the alternative conversion feature, and warrant anti-dilution adjustments, are contingent upon obtaining Stockholder Approval by February 23, 2026.
Risks: Failure to obtain Stockholder Approval by the deadline will result in a suspension of the ATM Facility and may prevent the implementation of the proposed conversion and warrant adjustments. The Company also faces the risk of failing to comply with Nasdaq Listing Rules without the proposed reverse stock split.
Investor Verification Checklist
- Verify the status of the pending Stockholder Approval required by February 23, 2026.
- Confirm the current trading price relative to the $2.00 per share floor for ATM sales prior to approval.
- Review the full text of the Omnibus Amendment and Waiver (Exhibit 10.1) for specific legal definitions of "Stockholder Approval" and "Conversion Price."
- Monitor Nasdaq compliance status regarding the proposed reverse stock split.
- Check for subsequent filings regarding the $20 million potential offering.